• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Neurosearch

edit

NeuroSearch (NEUR) is a Scandinavian biopharmaceutical company listed on the Nasdaq OMX Copenhagen A/S.

The core business of the company covers the development of novel pharmaceutical agents, based on a broad and well-established drug discovery platform focusing on ion channels and central nervous system (CNS) disorders.

A substantial share of the activities is partner financed through strategic alliances with Eli Lilly and Company, Janssen Pharmaceutica and GlaxoSmithKline (GSK), and a license collaboration with Abbott.

In addition, NeuroSearch has a broad portfolio of preclinical drug candidates and holds equity interests in several biotech companies.

The company has approximately 220 employees with activities in Ballerup and Gothenburg.

Milestones

edit

• 
  Neurosearch invested in NsGene. (5/2/05)
  Posted 8/30/10 at 5:03am via nsgene.dk
• 
  Neurosearch received $14.3M in Unattributed funding. (8/17/09)
  Posted 9/28/09 at 2:00am via neurosearch.com

Videos

Screenshots

edit

Above: Neurosearch Screenshot -- #1
Uploaded: 9/28/09

Sources

1. NsGene A/S moves towards clinical development with an additional DKK 30 million and introduces a new investor. (nsgene.dk) [edit]
2. NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV (neurosearch.com) [edit]